FDA Considers Second COVID-19 Booster Shot
The authorization would depend on ongoing studies, which must show that a fourth dose would increase waning immunity and reduce the risk of severe disease. WebMD Health News …read more
Data Review: Spironolactone Not Linked to Increased Cancer Risk
The drug’s antiandrogenic properties have driven its off-label use as a treatment for acne, hidradenitis, androgenetic alopecia, and hirsutism, and it is also used in gender-affirming care. Medscape Medical News …read more
Obstetric Care for Gender Diverse Patients
Two presentations at the recent Society of Maternal and Fetal Medicine Pregnancy Meeting provide a comprehensive outlook on the unique reproductive care needs of this growing population. Medscape Ob/Gyn …read more